Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Morisaki

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Current Medicinal Chemistry|October 8, 2003
Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancerTakashi Morisaki, Mitsuo Katano
Anticancer Research|May 30, 2012
Cancer immunotherapy using NKG2D and DNAM-1 systemsTakashi Morisaki, Hideya Onishi, Mitsuo Katano
Anticancer Research|March 9, 2012
Immunotherapy approaches targeting regulatory T-cellsHideya Onishi, Takashi Morisaki, Mitsuo Katano
Anticancer Research|August 30, 2011
Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancerAkio Yamasaki, Hideya Onishi, Takashi Morisaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
[A resected case of advanced gastric cancer with multiple liver metastasis successfully treated by preoperative and postoperative S-1/CPT-11 combination chemotherapy]Kotaro Matsumoto, Takashi Morisaki, Tatsuya Hirano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2017
[Development of Holistic Cancer Treatment Centering Cancer Patients - From the Standpoint of Hypoxia and Hedgehog Signaling]Hideya Onishi, Toshitatsu Ogino, Takashi Morisaki, et al.
Applied Optics|August 4, 2012
Two-dimensional single-shot tomography using a virtually imaged phased array and a spatial phase modulatorTatsutoshi Shioda, Takashi Morisaki, Tuan Quoc Banh, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|March 9, 2011
[New immunotherapy against cancer: a therapy to control regulatory T cell]Hideya Onishi, Hiroyuki Suzuki, Nobuhito Chikazawa, et al.
Clinical Immunology (Orlando, Fla.)|December 4, 2012
Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancerHiroyuki Suzuki, Hideya Onishi, Takashi Morisaki, et al.
International Journal of Clinical Oncology|February 18, 2011
Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/HER1-negative breast cancerHideya Onishi, Takashi Morisaki, Yuji Nakafusa, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Current Medicinal Chemistry|October 8, 2003
Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancerTakashi Morisaki, Mitsuo Katano
Anticancer Research|May 30, 2012
Cancer immunotherapy using NKG2D and DNAM-1 systemsTakashi Morisaki, Hideya Onishi, Mitsuo Katano
Anticancer Research|March 9, 2012
Immunotherapy approaches targeting regulatory T-cellsHideya Onishi, Takashi Morisaki, Mitsuo Katano
Anticancer Research|August 30, 2011
Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancerAkio Yamasaki, Hideya Onishi, Takashi Morisaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
[A resected case of advanced gastric cancer with multiple liver metastasis successfully treated by preoperative and postoperative S-1/CPT-11 combination chemotherapy]Kotaro Matsumoto, Takashi Morisaki, Tatsuya Hirano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2017
[Development of Holistic Cancer Treatment Centering Cancer Patients - From the Standpoint of Hypoxia and Hedgehog Signaling]Hideya Onishi, Toshitatsu Ogino, Takashi Morisaki, et al.
Applied Optics|August 4, 2012
Two-dimensional single-shot tomography using a virtually imaged phased array and a spatial phase modulatorTatsutoshi Shioda, Takashi Morisaki, Tuan Quoc Banh, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|March 9, 2011
[New immunotherapy against cancer: a therapy to control regulatory T cell]Hideya Onishi, Hiroyuki Suzuki, Nobuhito Chikazawa, et al.
Clinical Immunology (Orlando, Fla.)|December 4, 2012
Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancerHiroyuki Suzuki, Hideya Onishi, Takashi Morisaki, et al.
International Journal of Clinical Oncology|February 18, 2011
Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/HER1-negative breast cancerHideya Onishi, Takashi Morisaki, Yuji Nakafusa, et al.
Pageof 10